QQ客服 官方微博 反馈留言

	MiR-361-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at RPL22L1 and c-Met signaling
	Ma, Jing; Jing, Xiaotao; Chen, Zhuo; Duan, Zhenling; Zhang, Yan
刊名	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
	2018
卷号	11期号:5
关键词	miR-361-5p epithelial ovarian cancer epithelial-mesenchymal transition ribosomal protein L22 like 1
ISSN号	1936-2625
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3416535
专题	昆明医科大学
推荐引用方式 GB/T 7714	Ma, Jing,Jing, Xiaotao,Chen, Zhuo,et al. MiR-361-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at RPL22L1 and c-Met signaling[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,2018,11(5).
APA	Ma, Jing,Jing, Xiaotao,Chen, Zhuo,Duan, Zhenling,&Zhang, Yan.(2018).MiR-361-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at RPL22L1 and c-Met signaling.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,11(5).
MLA	Ma, Jing,et al."MiR-361-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at RPL22L1 and c-Met signaling".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 11.5(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。